“Citydel” business center preparing to accommodate a new tenant
“Citydel” business center which is operated by Prime Property Management company is preparing to accommodate a new tenant which is represented by one of the Russian leading pharmaceutical manufacturers.
New tenant will occupy the office with an area of 2 846. 4 square meters.
At the present moment “Akrikhin” is quickly developing and, as a consequence, has come to face the necessity of its office area expansion. “In “Citydel” business center we saw an opportunity to arrange a new, modern office with the maximum efficient planning, having considered the possibility to allocate not only working spaces for our staff, but also recreational ones.” – said Natalia Duvanova, HR Director at “Akrikhin”.
“Citydel” business center, with its public space zones having been renovated by the end of 2017, is a perfect place for the accommodation of an office. Due to its comfortable location, well-developed infrastructure and competent management, “Citydel” attracts tenants from a number of Russian and international companies.
“We are glad that such company as “Akrikhin”, with a long-term history and big perspectives, has become our tenant, - remarked Pavel Tiger, Tenants Relationship Director at Prime Property Management company. – I’m sure that due to its good planning, the chosen office premises will allow “Akrikhin” company to make their “dream office” become a reality.
Additional information
Information on “Akrikhin”
JSC “Akrikhin” is one of the leading Russian pharmaceutical companies, producing effective, affordable, high-quality medicine mostly demanded by Russian patients of therapy groups.
In terms of its sales result, the company is one of the leading local pharmaceutical manufacturers on the Russian pharmaceutical market, showing considerable growth and development rate.
There are about 200 medicine products in the product portfolio of “Akrikhin” company, with more than one hundred being manufactured at the production space in Moscow region. The medical products relate to the major pharmaceutical lines: tuberculosis, diabetes, dermatology, cardiololgy, neurology, gynecology and other, being produced in accordance with GMP standards.